16 citations as recorded by crossref.

1. A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic courses E. Faller & A. Jackson https://doi.org/10.1080/1120009X.2022.2145452
2. Effectiveness and safety of dalbavancin in France: a prospective, multicentre cohort study J. Courjon et al. https://doi.org/10.1016/j.ijantimicag.2023.106945
3. Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable In Situ-Forming Depot Antibiotics Delivery System A. Fuglsang-Madsen et al. https://doi.org/10.1093/infdis/jiae139
4. Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed? L. Prats-Peinado et al. https://doi.org/10.3390/antibiotics13060538
5. Clinical results of using a silver-containing preparation as part of an antimicrobial spacer in the treatment of periprosthetic hip joint infection S. Bozhkova et al. https://doi.org/10.18019/1028-4427-2024-30-6-822-830
6. Update on Coagulase-Negative Staphylococci—What the Clinician Should Know R. Michels et al. https://doi.org/10.3390/microorganisms9040830
7. Effectiveness of Different Antimicrobial Strategies for Staphylococcal Prosthetic Joint Infection: Results From a Large Prospective Registry-Based Cohort Study H. Scheper et al. https://doi.org/10.1093/ofid/ofac474
8. Uncommon Septic Arthritis of the Hip Joint in an Immunocompetent Adult Patient Due to Bacillus pumilus and Paenibacillus barengoltzii Managed with Long-Term Treatment with Linezolid: A Case Report and Short Literature Review R. Cismasiu et al. https://doi.org/10.3390/ph16121743
9. The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection O. Gordon et al. https://doi.org/10.1128/spectrum.02451-21
10. Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects K. Veerman et al. https://doi.org/10.1093/jac/dkad276
11. Antimicrobials in Orthopedic Infections: Overview of Clinical Perspective and Microbial Resistance B. Huzum et al. https://doi.org/10.3390/medicina60121988
12. Management of Gram-positive multiresistant bacteria prosthetic joint infection: a narrative review on current and innovative strategies F. Valour et al. https://doi.org/10.1016/j.cmi.2025.04.021
13. From remote to urbanized: Dispersal of antibiotic-resistant bacteria under the aspect of anthropogenic influence D. Gattinger et al. https://doi.org/10.1016/j.scitotenv.2024.171532
14. Choice of Antibiotics for the Treatment of Orthopedic Infection Caused by Gram-Positive Pathogens, Based on a 12-Year Follow-Up. Part 1: Penicillins, Cephalosporins, Glycopeptides, Oxazolidinones, Fusidic Acid, Rifampicin A. Kasimova et al. https://doi.org/10.17816/2311-2905-17680
15. Two-Stage Revision Arthroplasty for Resistant Gram-Positive Periprosthetic Joint Infections Using an Oral Linezolid-Based Antibiotic Regime L. Gründer et al. https://doi.org/10.3390/antibiotics12081235
16. Real-World Comparison of Intravenous vs. Oral Antimicrobial Therapy for Bone and Joint Infections M. Kreiser et al. https://doi.org/10.3390/pharmacy14020048